Arcutis Biotherapeutics

General Information


We are a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Our current portfolio is comprised of topical treatments with significant potential to address immune-mediated dermatological diseases and conditions, or immuno-dermatology. Our strategy is to identify and develop treatments against validated biological targets in dermatology that deliver a differentiated clinical profile that addresses major shortcomings of existing therapies in our targeted indications.

Employees: 29
Founded: 2016
Contact Information
Address 2945 Townsgate Road, Suite 110, Westlake Village, CA 91361, US
Phone Number (805) 418-5006
Web Address
View Prospectus: Arcutis Biotherapeutics
Financial Information
Market Cap $561.0mil
Revenues $0 mil (last 12 months)
Net Income $-35.0 mil (last 12 months)
IPO Profile
Symbol ARQT
Exchange NASDAQ
Shares (millions): 9.4
Price range $17.00 - $17.00
Est. $ Volume $159.4 mil
Manager / Joint Managers Goldman Sachs/ Cowen and Company/ Guggenheim Securities
CO-Managers Cantor Fitzgerald
Expected To Trade: 1/31/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change